306 related articles for article (PubMed ID: 19825996)
41. Silencing of CXCR4 inhibits the proliferation, adhesion, chemotaxis and invasion of salivary gland mucoepidermoid carcinoma Mc3 cells in vitro.
Wen DS; Zhu XL; Guan SM; Wu YM; Yu LL; Wu JZ
Oral Oncol; 2008 Jun; 44(6):545-54. PubMed ID: 17936060
[TBL] [Abstract][Full Text] [Related]
42. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour.
van der Meulen AA; Biber K; Lukovac S; Balasubramaniyan V; den Dunnen WF; Boddeke HW; Mooij JJ
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):579-91. PubMed ID: 19627512
[TBL] [Abstract][Full Text] [Related]
43. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
44. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion.
Miyanishi N; Suzuki Y; Simizu S; Kuwabara Y; Banno K; Umezawa K
Biochem Biophys Res Commun; 2010 Dec; 403(1):154-9. PubMed ID: 21059341
[TBL] [Abstract][Full Text] [Related]
45. Altered CXCL12 expression reveals a dual role of CXCR4 in osteosarcoma primary tumor growth and metastasis.
Neklyudova O; Arlt MJ; Brennecke P; Thelen M; Gvozdenovic A; Kuzmanov A; Robl B; Botter SM; Born W; Fuchs B
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1739-50. PubMed ID: 27300512
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
[TBL] [Abstract][Full Text] [Related]
47. Cell-penetrating and endoplasmic reticulum-locating TAT-IL-24-KDEL fusion protein induces tumor apoptosis.
Zhang J; Sun A; Xu R; Tao X; Dong Y; Lv X; Wei D
J Cell Physiol; 2016 Jan; 231(1):84-93. PubMed ID: 26031207
[TBL] [Abstract][Full Text] [Related]
48. [Shikonin down-regulates CXCR4 expression and inhibits CXCL12-induced migratory responses in colorectal carcinoma cell line SW480].
Wen ZF; Wei XQ; Guo YW; Zheng FP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):627-9. PubMed ID: 19921580
[TBL] [Abstract][Full Text] [Related]
49. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
Otani Y; Kijima T; Kohmo S; Oishi S; Minami T; Nagatomo I; Takahashi R; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Fujii N; Kumanogoh A
FEBS Lett; 2012 Oct; 586(20):3639-44. PubMed ID: 22992418
[TBL] [Abstract][Full Text] [Related]
50. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
51. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
52. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
[TBL] [Abstract][Full Text] [Related]
53. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
55. Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.
Ray P; Lewin SA; Mihalko LA; Schmidt BT; Luker KE; Luker GD
Neoplasia; 2011 Dec; 13(12):1152-61. PubMed ID: 22241961
[TBL] [Abstract][Full Text] [Related]
56. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
[TBL] [Abstract][Full Text] [Related]
57. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
58. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
Ok S; Kim SM; Kim C; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):768-78. PubMed ID: 22299827
[TBL] [Abstract][Full Text] [Related]
59. Novel guanide-substituted compounds bind to CXCR4 and inhibit breast cancer metastasis.
Shepard JB; Wilkinson RA; Starkey JR; Teintze M
Anticancer Drugs; 2014 Jan; 25(1):8-16. PubMed ID: 24045366
[TBL] [Abstract][Full Text] [Related]
60. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X
Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
